CRISPR pioneer Feng Zhang launches a ‘limitless’ biotech upstart with big plans for speeding new drug development – Endpoints News
Endpoints News |
CRISPR pioneer Feng Zhang launches a 'limitless' biotech upstart with big plans for speeding new drug development
Endpoints News The biotech came out of stealth mode today with a $15.6 million round, which we've been tracking, and a plan to employ the CRISPR system with a platform tech built around artificial intelligence, genome sequencing, gene synthesis and screening efforts … Stealth biotech Arbor steps out of the shadows, announcing it's found a new CRISPR enzyme Arbor Biotechnologies Discovers New CRISPR System Utilizing its Discovery Platform |
